Found: 1
Select item for more details and to access through your institution.
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 2, p. 201, doi. 10.1093/jpids/piaa039
- By:
- Publication type:
- Article